Press Releases by Category Health & Medicine
Key Driver Reshaping the Replagal Market in 2025: Impact Of Increasing Research …
What Are the Projections for the Size and Growth Rate of the Replagal Market?
In recent times, the market size for replagal has seen a healthy CAGR of $XX. The market is projected to escalate from $XX million in 2024 to $XX million the following year, with a compound annual growth rate (CAGR) of $XX%. Factors such as a rising number of Fabry disease cases, enhancements in global healthcare access, escalating…
In-Depth Analysis of the Tysabri (natalizumab) Market: Growth Opportunities, Key …
What Are the Projected Growth and Market Size Trends for the Tysabri (natalizumab) Market?
In recent times, the market size of Tysabri (Natalizumab) has witnessed a robust growth. Predictions suggest a rise from $2,460 million in 2024 to $2,660 million in 2025, maintaining an 8.1% compound annual growth rate (CAGR). This rise during the historic period is credited to its effectiveness in treating multiple sclerosis, the capacity to target specific immune…
Autoplex Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
How Big Is the Autoplex Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the autoplex market has experienced a healthy compound annual growth rate of $XX%. Its size is expected to expand from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of $XX%. The historical progression can be credited to multiple factors, such as higher occurrence of…
Key Companion Animal Diagnostics Market Driver for 2025-2034: Rising Number Of P …
What Is the Future Outlook for the Companion Animal Diagnostics Market's Size and Growth Rate?
The dimension of the companion animal diagnostics market has witnessed significant growth recently. The market value is expected to rise from $3.1 billion in 2024 to $3.4 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. The surge in growth at this historical juncture can be credited to several factors. These include an…
Increasing Diagnosis Of Genetic Disorders Driving The Growth Of The Panhematin M …
What Are the Projections for the Size and Growth Rate of the Panhematin Market?
The market size for panhematin has seen a swift expansion in the recent past. Expected to increase from $2,157.14 million in 2024 to $2,421.17 million in 2025, it will be experiencing a compound annual growth rate (CAGR) of 12.3%. The increased prevalence of Acute Intermittent Porphyria (AIP), amplified awareness about uncommon genetic disorders, rising healthcare costs, the…
A Deep Dive into Anascorp Market 2025: Key Drivers, Growth Factors, and Projecti …
How Big Is the Anascorp Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the anascorp market dimension has seen an $XX. Its projection is to rise from $XX million in 2024 to $XX million in 2025, equating to a compound annual growth rate (CAGR) of $XX%. The growth observed in the previous period owes its success to factors such as an increase in scorpion sting…
Prominent Simulect Market Driver for 2025: Simulect Market Growth Driven By High …
What Are the Projected Growth and Market Size Trends for the Simulect Market?
In recent times, the simulect market size has seen an HCAGR of $XX. The projection for growth is estimated from $XX million in 2024 to $XX million in 2025, achieving a compound annual growth rate (CAGR) of $XX%. The upswing in the historical phase is ascribed to regulatory authorities' approval, a transition towards biologic therapies, a surge in…
What's Driving the Imfinzi (durvalumab) Market 2025-2034: Impact Of Rising Cance …
What Are the Projections for the Size and Growth Rate of the Imfinzi (durvalumab) Market?
In the last few years, the market size of imfinzi (durvalumab) has seen a dramatic surge. It is projected to increase from $2,701.22 million in 2024 to $3,013.33 million in 2025, having a compound annual growth rate (CAGR) of 11.6%. Factors like expanded indications and approvals, the growing demand for targeted and personalized treatments, advances in…
Top Factor Driving Allocord Market Growth in 2025: Rising Chronic Diseases Boost …
How Big Is the Allocord Market Expected to Be, and What Will Its Growth Rate Be?
The market size of allocord has surged to $XX over the past few years. The projected growth from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of $XX%, demonstrates its escalating trend. Factors that contributed to this expansion during the historic period include the amplified prevalence of…
Rising Cancer Incidence Fuels Growth In The Proleukin Market Driver: Leading Tra …
What Are the Projected Growth and Market Size Trends for the Proleukin Market?
The market size of Proleukin has witnessed substantial growth in the past years. There will be an increase from $1,165.73 million in 2024 to $1,242.46 million in 2025 with a compound annual growth rate (CAGR) of 6.6%. Factors such as better accessibility of Proleukin in international markets, improved insurance coverage for immunotherapy medications, increased acceptance of il-2-based treatments…
Key Trend Reshaping the Daratumumab Or Darzalex Market in 2025: Focus On Transme …
What Are the Projections for the Size and Growth Rate of the Daratumumab Or Darzalex Market?
The market for daratumumab, also known as darzalex, has experienced swift expansion in the last few years. It is projected to escalate from $5,093.04 million in 2024 to $5,618.30 million in 2025 with a compound annual growth rate (CAGR) of 10.3%. This substantial growth during the historic period is primarily due to the use of…
Acthib, Omnihib Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market …
How Big Is the Acthib, Omnihib Market Expected to Be, and What Will Its Growth Rate Be?
The market size for acthib, omnihib has experienced an $XX increase in the last few years. The estimated growth is from $XX million in 2024 to $XX million in 2025, marking a compound annual growth rate (CAGR) of $XX%. The growth seen in the historic period could be tied to developments in global immunization…
Trasylol (Aprotinin) Market Outlook 2025-2034: Key Trends, Growth Drivers, and M …
How Big Is the Trasylol (Aprotinin) Market Expected to Be, and What Will Its Growth Rate Be?
The market size for trasylol (aprotinin) has seen considerable growth in the past few years. An increase is projected from $2,08,480 million in 2024 to $2,28,270 million in 2025 with a Compound Annual Growth Rate (CAGR) of 9.5%. This significant growth during the historical period is primarily due to the rising demand for aprotinin,…
Rising Cardiovascular Diseases Fuel Growth In The Cathflo Activase (Alteplase) M …
What Are the Projections for the Size and Growth Rate of the Cathflo Activase (Alteplase) Market?
The market size of cathflo activase (alteplase) has significantly expanded in the past few years. Its growth will continue, increasing from $1,469.61 million in 2024 to $1,593.15 million in 2025, with a compound annual growth rate (CAGR) of 8.4%. The increase during the historical period is due to factors such as its growing off-label application,…
Urinary Tract Infection (UTI) Treatment Market Estimated to Grow at 5.5% CAGR by …
Introduction
Urinary tract infections (UTIs) are among the most prevalent bacterial infections affecting millions of individuals worldwide each year. These infections occur when bacteria, primarily Escherichia coli (E. coli), invade the urinary system, leading to symptoms such as pain, frequent urination, and discomfort. While UTIs are commonly treated with antibiotics, the growing concern of antibiotic resistance and recurrent infections has spurred advancements in treatment options and innovative approaches.
The global urinary tract…
Key Driver Shaping the Saizen Market in 2025: Impact Of Rising Healthcare Expend …
How Big Is the Saizen Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size of Saizen has shown an $XX expansion. The prediction is that it will enlarge from $XX million in 2024 to $XX million in 2025, marking a compound annual growth rate (CAGR) of $XX%. The escalation in the historic era can be credited to increased awareness about growth hormone deficiency,…
Leading Growth Driver in the Cat Vaccine Market in 2025: Rising Zoonotic Disease …
What Are the Market Size and Growth Forecast for the Cat Vaccine Market?
There has been notable growth in the cat vaccine market size in the past few years. The market is projected to expand from $1.15 billion in 2024 to $1.26 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. Factors contributing to the growth during the past period include the surge of new diseases affecting cats,…
What's Driving the Anthrasil Market 2025-2034: Rising Anthrax Infections Drive I …
What Are the Projections for the Size and Growth Rate of the Anthrasil Market?
In recent times, the anthrasil market has experienced a substantial increase of $XX. Bouncing from $XX million in 2024, it is projected to reach $XX million in 2025, delivering a compound annual growth rate (CAGR) of $XX%. The historically visible growth can be credited to heightened cognizance of bioterrorism risks, the discovery of new instances of anthrax,…
In-Depth Analysis of the Omnitrope Market: Growth Opportunities, Key Trends, and …
What Are the Projected Growth and Market Size Trends for the Omnitrope Market?
Recent years have witnessed a fast-paced expansion in the size of the Omnitrope market. It's projected to swell from $3,888.46 million in 2024 to $4,290.64 million in 2025, registering a compound annual growth rate (CAGR) of 10.3%. The surge observed in the historical phase is credited to an increase in the number of patients with growth hormone deficiencies,…
Top Factor Driving Prolastin, Prolastin-C Market Growth in 2025: Rising Respirat …
How Big Is the Prolastin, Prolastin-C Market Expected to Be, and What Will Its Growth Rate Be?
In recent years, the prolastin, prolastin-C market has experienced a growth rate of $XX. This market, which amounted to $XX million in 2024, is anticipated to reach $XX million in 2025, expanding at a compound annual growth rate (CAGR) of $XX%. Factors contributing to this growth during the historic period include heightened awareness of…
Key Driver Reshaping the Aimovig Market in 2025: Rising Migraine Incidence Fuels …
What Are the Projections for the Size and Growth Rate of the Aimovig Market?
The growth in size of the aimovig market has been consistently at $XX in recent years. It's predicted that the market will expand from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of $XX%. Several factors account for the historical growth, including increasing occurrence of migraine disorders, breakthroughs in…
Prominent Erbitux Market Trend for 2025: Enzene Biosciences Launches Affordable …
What Are the Projected Growth and Market Size Trends for the Erbitux Market?
The market size of erbitux has seen quick expansion in the recent past. The growth is projected from $1,312.93 million in 2024 to $1,559.39 million in 2025 representing an annual compound growth rate (CAGR) of 18.8%. The expansion in the historic period can be credited to economical pricing strategies, a rise in awareness and early detection, alterations in…
Neupogen (filgrastim) Market Outlook 2025-2034: Key Trends, Growth Drivers, and …
How Big Is the Neupogen (filgrastim) Market Expected to Be, and What Will Its Growth Rate Be?
In the recent past, the market size of neupogen (filgrastim) has seen a significant surge. The sector is expected to boost from $1,330.69 million in 2024, reaching up to $1,404.70 billion in 2025 with a compound annual growth rate (CAGR) of 5.6%. Factors such as a surge in cancer cases, increased understanding of chemotherapy-induced…
Rising Incidence Of Bladder Cancer Fuels Adstiladrin Market Growth: A Key Factor …
What Are the Projections for the Size and Growth Rate of the Adstiladrin Market?
In recent years, the adstiladrin market size has experienced a $XX surge. There will be a rise from $XX million in 2024 to $XX million in 2025, indicating a compound annual growth rate (CAGR) of $XX%. The significant escalation during the historic period is due to factors such as heightened approval for gene therapy products, a surge…
Rising Number of Clinical Trials To Accelerate Growth In The Crysvita Market Dri …
What Are the Projected Growth and Market Size Trends for the Crysvita Market?
In recent years, the market size of Crysvita has grown at an $XX. The market, which is forecasted to expand from $XX million in 2024 to $XX million in 2025, is projected to grow at a compound annual growth rate (CAGR) of $XX%. The historic growth can be linked to a greater emphasis on early detection and treatment…
Shaping the Enbrel Mini Market in 2025: Lupin Pharmaceutical Launches Biosimilar …
How Big Is the Enbrel Mini Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size of Enbrel Mini has expanded by $XX. The market is projected to expand from $XX million in 2024 to $XX million in 2025, marking a compound annual growth rate (CAGR) of $XX%. The surge during the historical period can be ascribed to factors such as rising incidence of…
In-Depth Analysis of the Besponsa Market: Growth Opportunities, Key Trends, and …
What Are the Projected Growth and Market Size Trends for the Besponsa Market?
The market size of Besponsa has been on an upward trajectory in recent years. The projection is that it will inflate from $217.99 million in 2024 to $236.63 million in 2025, reflecting a compound annual growth rate (CAGR) of 8.5%. Factors that contributed to this growth during the historical period are the increasing cases of relapsed or refractory…
Top Factor Driving Comirnaty (Tozinameran) Market Growth in 2025: Rising Infecti …
How Big Is the Comirnaty (Tozinameran) Market Expected to Be, and What Will Its Growth Rate Be?
In the last few years, there has been an extraordinary increase in the market size for comirnaty (tozinameran). It is projected to reach from $6,783.04 million in 2024 to $8,264.11 million in 2025, equating to an annual growth rate (CAGR) of 21.8%. The escalation seen in the past is linked to factors such as…
Labor Outsourcing Service Market Size by Application, Type, Geographic Scope, an …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to Market Research Intellect, the global Labor Outsourcing Service market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for labor outsourcing services has grown significantly as businesses put more of an emphasis on cutting expenses while increasing productivity. Businesses can…
Avonex Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
How Big Is the Avonex Market Expected to Be, and What Will Its Growth Rate Be?
There has been a robust expansion in the avonex market size in the past few years. The market is forecasted to surge from $1,836.58 million in 2024 to $1,949.35 million in 2025, with a compound annual growth rate (CAGR) of 6.1%. This robust growth seen in the past is due to factors such as the…
Prominent Alphanine SD Market Driver for 2025: Growing Hemophilia Prevalence Dri …
What Are the Projected Growth and Market Size Trends for the Alphanine SD Market?
In the past few years, the alphanine SD market's dimensions have demonstrated an $XX. This market's worth is set to escalate from a total of $XX million in 2024 to $XX million in 2025, marking a compound annual growth rate (CAGR) of $XX%. The expansion during the historic period can be credited to the heightened consciousness of…
Key Driver Shaping the Albuminar-25 Market in 2025: The Demand For Biopharmaceut …
How Big Is the Albuminar-25 Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been a considerable expansion in the albuminar-25 market, with an HCAGR of $XX. The market, which was worth $XX million in 2024, is projected to reach $XX million in 2025, reflecting a Compound Annual Growth Rate (CAGR) of $XX%. A number of factors have contributed to this historical growth, including…
Small Molecule CMO/CDMO Market Anticipated to Hit USD 114.17 Billion by 2032: Pe …
Introduction
The pharmaceutical industry is undergoing rapid transformation, with companies increasingly relying on contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) for drug production. Among these, the small molecule CMO/CDMO market has seen substantial growth due to rising demand for outsourced drug development and manufacturing. Small molecules remain a dominant segment in the pharmaceutical industry, accounting for a significant portion of marketed drugs and new drug approvals.
According to…
Top Factor Driving ADZYNMA Market Growth in 2025: Impact Of Rising Autoimmune Di …
How Big Is the ADZYNMA Market Expected to Be, and What Will Its Growth Rate Be?
In recent years, the market size of ADZYNMA has seen an increase of $XX. Its growth is predicted to accelerate from $XX million in 2024 to $XX million in 2025, showing a compound annual growth rate (CAGR) of $XX%. The historical growth of this market is credited to the spike in chronic disease rates, a…
Activase (Alteplase) Market Outlook 2025-2034: Key Trends, Growth Drivers, and M …
How Big Is the Activase (Alteplase) Market Expected to Be, and What Will Its Growth Rate Be?
The market for activase (alteplase) has seen robust growth in the recent past. The market size is forecasted to expand from $1,457.68 million in 2024 to $1,577.10 million in 2025, indicating a compound annual growth rate (CAGR) of 8.2%. Various factors have contributed to this growth over the historic period, including the growth in…
Impact Of Rising Influenza Prevalence On The Growth Of The Afluria Quadrivalent …
What Are the Projected Growth and Market Size Trends for the Afluria Quadrivalent Market?
The market size for afluria quadrivalent has witnessed a Compound Annual Growth Rate of $XX in the past few years. Forecasts predict an escalation from a worth of $XX million in 2024 to $XX million in 2025, positing a Compound Annual Growth Rate (CAGR) of $XX%. The growth experienced in the previous duration has occurred due to…
Key Biochemistry Analyzers Market Driver for 2025-2034: Rising Chronic Disorders …
What Is the Future Outlook for the Biochemistry Analyzers Market's Size and Growth Rate?
In recent times, the biochemistry analyzers market has witnessed robust growth. Its expansion will rise from $4.5 billion in 2024 to $4.82 billion in 2025, posting a compound annual growth rate (CAGR) of 7.1%. Factors contributing to the growth during the historic period include enhanced healthcare spending, prioritization of early disease diagnosis, accelerated research and development, increased…
In-Depth Analysis of the Adbry/Adtralza Market: Growth Opportunities, Key Trends …
What Are the Projected Growth and Market Size Trends for the Adbry/Adtralza Market?
The market for adbry/adtralza has recently seen a sizeable increase of $XX. The growth is anticipated to go from $XX million in 2024 to $XX million in 2025, showcasing a compound annual growth rate (CAGR) of $XX%. The observed growth during the historical period is mainly credited to FDA approval, wider acceptance by dermatologists, regulation advancements, market expansion,…
Endothelial Dysfunction Market Latest Trends and Growth Factors Analysis 2024 to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Endothelial Dysfunction Market- (By Cause (Hypertension, Diabetes, Hypercholesterolemia, Baches's disease, Obesity, Others), By Test Type (Invasive, Non-invasive tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Plethysmography, Circulatory Markers, Others)), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce…
Dental Imaging Market Projected to Reach USD 7 Billion by 2032, Driven by Techno …
Introduction
The global dental imaging market is witnessing significant growth, with projections indicating it will reach USD 7 billion by 2032. This expansion is fueled by technological advancements, rising prevalence of dental disorders, and increasing demand for precision diagnostics. The shift toward digital imaging solutions, along with innovations in AI-based dental imaging, is further driving market expansion. As dental care becomes more patient-centric and technologically advanced, the adoption of sophisticated imaging…
Emergency Patient Data Analysis Market Investments, Share and Revenue Analysis R …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Emergency Patient Data Analysis Market- (By Type (Descriptive, Prescriptive, Predictive), By Application (Financial, Operational, Clinical), By End-User (Providers, Payer)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Emergency Patient Data Analysis Market is valued at US$ 28.23 Bn in 2022, and it is expected to…
Aurora Kinase B Global Market Report 2025
What Are the Market Size and Growth Forecast for the Aurora Kinase B Market?
In recent times, the market size for aurora kinase b has witnessed a fast-paced growth. The market that was worth $1.14 billion in 2024 is forecasted to rise to $1.27 billion in 2025, boasting a compound annual growth rate of 12.1%. Factors contributing to this growth during the historic period include the escalating demand for cancer-specific therapies,…
ELISpot and FluoroSpot Assay Market Demand and Growth Opportunities Detailed Ana …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global ELISpot and FluoroSpot Assay Market- (By Product (Assay Kits (Assay Kits by Technique(ELISpot Assay Kits, FluroSpot Assay Kits), Assay Kits by Utility (Diagnostic Kits, Research Kits), Assay Kits by Analyte (T-cell-based kits, B-cell-based kits, Other analytic kits), Analyzers, Ancillary products), By Application (Diagnostic Applications (Infectious Diseases, Transplants), Research Applications (Vaccine Development, Clinical Trials, Cancer Research)),…
Clinical Trials Market Set for Robust Expansion Amidst Advancements in Medical R …
Clinical Trials Market size was valued at US $ 55.89 Billion in 2023 and the total Market revenue is expected to grow at 6.1% through 2024 to 2030, reaching nearly US $ 84.59 Billion. This growth is primarily driven by the increasing demand for novel therapies, the rising prevalence of chronic diseases, and the ongoing advancements in medical research methodologies.
𝐖𝐚𝐧𝐭 𝐭𝐨 𝐒𝐞𝐞 𝐭𝐡𝐞 𝐓𝐫𝐞𝐧𝐝𝐬? 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨𝐝𝐚𝐲:https://www.stellarmr.com/report/req_sample/Clinical-Trials-Market/802…
Circulating Tumor Cells Market to Reach US$ 31.67 Billion by 2032, Growing at a …
The Circulating Tumor Cells (CTC) market is projected to experience significant growth, driven by advancements in cancer diagnostics and personalized medicine. CTCs, which are cancer cells that have detached from the primary tumor and entered the bloodstream, offer valuable insights into tumor progression and metastasis. Their detection and analysis enable early cancer detection, monitoring of treatment efficacy, and assessment of recurrence risk.
Circulating Tumor Cells Market size was valued at US$…
Global Epilepsy Monitoring Devices Market Set for Robust Growth, Projected to Re …
The global epilepsy monitoring devices market is on a strong growth trajectory, with projections estimating a market value of USD 523.26 million in 2023. According to recent industry reports, this market is set to grow significantly over the next decade, reaching USD 894.63 million by 2033. This represents a substantial compound annual growth rate (CAGR) of 5.5% during the forecast period.
Epilepsy, a common neurological disorder affecting millions worldwide, necessitates continuous…
Global Pain Management Devices Market Poised for Significant Growth, Projected t …
The global pain management devices market is set to experience robust growth, with sales projected to rise from USD 3,019.8 million in 2025 to an estimated USD 5,727.5 million by 2035. This represents a steady compound annual growth rate (CAGR) of 6.6% over the forecast period.
The market, which generated USD 2,855.7 million in revenue in 2024, is driven by increasing cases of chronic pain conditions, advancements in medical technology, and…
Eosinophilic Esophagitis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, …
DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Eosinophilic Esophagitis pipeline landscape. It covers the Eosinophilic Esophagitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Eosinophilic Esophagitis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's…
ER+/ HER2 -ve Breast Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approval …
DelveInsight's, "ER positive, HER2 negative Breast Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in ER positive, HER2 negative Breast Cancer pipeline landscape. It covers the ER+/ HER2 -ve Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ER+/ HER2 -ve Breast Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights…
Advanced Recurrent Ovarian Cancer Clinical Trials and Studies: EMA, PDMA, FDA Ap …
DelveInsight's, "Advanced Recurrent Ovarian Cancer Pipeline Insight" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Advanced Recurrent Ovarian Cancer pipeline landscape. It covers the Advanced Recurrent Ovarian Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Advanced Recurrent Ovarian Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Go To Page 10161 10160 10159 10158 10157 10156 10155 10154 10153 10152
